文献速递脑血管病

循环代谢物作为卒中风险预测候选生物标志物:BiomarCaRE项目结果

Circulating Metabolites Are Biomarker Candidates for Stroke Risk Prediction: Results From the BiomarCaRE Project
RSS 订阅 · Stroke

在中位随访8.9年期间,6种代谢物与卒中发病风险显著相关。其10年预测区分度与经典心血管危险因素相近。

要点

  • 6种循环代谢物与卒中发病风险独立显著相关。
  • 代谢物组合的10年预测区分度接近经典心血管危险因素。
  • 谷氨酸每增加1个标准差,卒中风险升高23%。

核心结论

  • 6种循环代谢物(2种二酰磷脂酰胆碱、2种溶血磷脂酰胆碱、1种羟基鞘磷脂和谷氨酸)与卒中发病风险显著相关。

研究设计与样本

  • 中位随访时间8.9年(四分位距4.4–14.7)。
  • 采用加权Cox比例风险模型,并校正经典危险因素。

主要发现

  • 中位年龄56.8岁(四分位距49.5–62.4),女性占39.5%。
  • 6种代谢物与卒中发病风险显著相关,关联强度与经典心血管危险因素相近。

关键数值与推荐

  • 溶血磷脂酰胆碱a C18:2每增加1个标准差,卒中风险HR为0.88(95%CI 0.82–0.93)。
  • 溶血磷脂酰胆碱a C17:0每增加1个标准差,卒中风险HR为0.88(95%CI 0.83–0.94)。
  • 羟基鞘磷脂C14:1每增加1个标准差,卒中风险HR为0.90(95%CI 0.85–0.94)。
  • 二酰磷脂酰胆碱C34:1每增加1个标准差,卒中风险HR为1.10(95%CI 1.05–1.16)。
  • 二酰磷脂酰胆碱C32:1每增加1个标准差,卒中风险HR为1.14(95%CI 1.08–1.21)。

临床怎么用

  • 循环代谢物可作为卒中风险预测的候选生物标志物,但尚不能替代经典危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. BACKGROUND:Stratification of stroke risk remains challenging, but metabolomic profiling offers the potential to detect new biomarkers and to improve early risk assessment of incident stroke. The objective of this study was to evaluate the association between circulating metabolites and the incidence of stroke in a case-cohort study conducted across several large population-based European cohorts.METHODS:Following the case-cohort design, a subset of 10 299 individuals, including all individuals with incident stroke, was selected from the original cohort of >70 000 individuals. The case-cohort design used a random subsample of the selected population cohorts, supplemented with cases not sampled in this random subcohort. A total of 141 circulating metabolites were measured from serum samples of the selected individuals, and associations of these metabolites with risk of incident stroke were estimated and compared with those of classic risk factors (sex, age at examination, systolic blood pressure, total cholesterol, body mass index, diabetes, daily smoking status, and antihypertensive treatment). Associations with time to stroke were assessed using weighted Cox proportional hazards models adjusted for the classic risk factors. Hazard ratios (HRs) for the log-transformed metabolites were reported per 1 SD increase.RESULTS:Of the 70 195 individuals in the original cohort, 1516 (2.2%) experienced incident strokes during a median follow-up time of 8.9 years (interquartile range, 4.4–14.7). Median age was 56.8 years (interquartile range, 49.5–62.4), and 39.5% were female. Six of the 141 metabolites (2 diacyl-phosphatidylcholines, 2 lyso-phosphatidylcholines, 1 hydroxysphingomyelin, and glutamic acid) remained significantly associated with incident stroke after correction for multiple comparisons (adjusted HRs [95% CIs] per SD: lyso-phosphatidylcholines a C18:2 HR, 0.88 [95% CI, 0.82–0.93], lyso-phosphatidylcholines a C17:0 HR, 0.88 [95% CI, 0.83–0.94], hydroxysphingomyelin C14:1 HR, 0.90 [95% CI, 0.85–0.94], diacyl-phosphatidylcholines C34:1 HR, 1.10 [95% CI 1.05–1.16], diacyl-phosphatidylcholines C32:1 HR, 1.14 [95% CI, 1.08–1.21], glutamic acid HR, 1.23 [95% CI 1.11–1.37]). The strengths of these associations were similar to those for classic cardiovascular risk factors (C statistics for 10-year prediction ranging from 0.782 to 0.785 for metabolites compared with 0.781 to 0.792 for classic cardiovascular risk factors).CONCLUSIONS:Among 10

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Circulating Metabolites Are Biomarker Candidates for Stroke Risk Prediction: Results From the BiomarCaRE Project

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。